AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $153 | +15.0% | 15,795 | -48.8% | 0.01% | -33.3% |
| Q4 2022 | $133 | -99.9% | 30,873 | +49.4% | 0.02% | 0.0% |
| Q2 2022 | $208,000 | -15.4% | 20,658 | +4.1% | 0.02% | 0.0% |
| Q1 2022 | $246,000 | -71.7% | 19,853 | -70.4% | 0.02% | -78.8% |
| Q2 2021 | $870,000 | +111.2% | 67,123 | +230.2% | 0.08% | +112.5% |
| Q4 2019 | $412,000 | +237.7% | 20,326 | -10.8% | 0.04% | +300.0% |
| Q3 2019 | $122,000 | +16.2% | 22,788 | +47.4% | 0.01% | +66.7% |
| Q4 2018 | $105,000 | +6.1% | 15,458 | -11.7% | 0.01% | +50.0% |
| Q2 2018 | $99,000 | -57.3% | 17,511 | -52.7% | 0.00% | -63.6% |
| Q3 2017 | $232,000 | – | 37,009 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |